Woo S, Park K, McPherson T, Woo J. Association of glucagon-like peptide 1 receptor agonist use with erythropoietic indices and anemia risk in diabetes. Blood Red Cells Iron. 2026;2(3):100089.
Woo S, Park K, McPherson T, Woo J. Association of glucagon-like peptide 1 receptor agonist use with erythropoietic indices and anemia risk in diabetes. Blood Red Cells Iron. 2026;2(3):100089. // Blood Red Cells & Iron. – URL: https://www.sciencedirect.com/science/article/pii/S3050598426000892?dgcid=rss_sd_all
Woo S, Park K, McPherson T, Woo J. Association of glucagon-like peptide 1 receptor agonist use with erythropoietic indices and anemia risk in diabetes. Blood Red Cells Iron. 2026;2(3):100089. Blood Red Cells & Iron. https://www.sciencedirect.com/science/article/pii/S3050598426000892?dgcid=rss_sd_all
“Woo S, Park K, McPherson T, Woo J. Association of glucagon-like peptide 1 receptor agonist use with erythropoietic indices and anemia risk in diabetes. Blood Red Cells Iron. 2026;2(3):100089.” Blood Red Cells & Iron.
@article{article38338,
title = {Woo S, Park K, McPherson T, Woo J. Association of glucagon-like peptide 1 receptor agonist use with erythropoietic indices and anemia risk in diabetes. Blood Red Cells Iron. 2026;2(3):100089.},
journal = {Blood Red Cells \& Iron},
url = {https://www.sciencedirect.com/science/article/pii/S3050598426000892?dgcid=rss_sd_all}
}